Literature DB >> 11700324

Phosphorylation of Pax2 by the c-Jun N-terminal kinase and enhanced Pax2-dependent transcription activation.

Yi Cai1, Mark S Lechner, Deepak Nihalani, Marc J Prindle, Lawrence B Holzman, Gregory R Dressler.   

Abstract

The Pax gene family encodes DNA-binding proteins that can both activate and repress transcription of specific target genes during embryonic development. Pax proteins are required for pattern formation and cell differentiation in a broad spectrum of developing tissues. Consistent with its expression in the intermediate mesoderm, the optic cup and stalk, and the otic vesicle, Pax2, a member of the Pax2/5/8 subfamily, is essential for the development of the renal epithelia, the optic cup, and the inner ear. In addition to a DNA binding domain, the Pax2 protein contains a carboxyl-terminal transactivation domain rich in serine, threonine, and tyrosine. In this report, we demonstrate that the Pax2 transactivation domain is phosphorylated by the c-Jun N-terminal kinase, but not the ERK1/2 or p38 MAP kinases and that phosphorylation is coincident with increased transactivation of a Pax2-dependent reporter gene. Activation of JNK by either upstream kinase MEKK1 or DLK or by expression of Wnt signaling proteins significantly enhances Pax2 phosphorylation in cells. In vitro kinase assays using immunoprecipitated JNK or constitutively active, recombinant JNK show phosphorylation of GST-Pax2 fusion proteins. In transfected cells, phosphorylation of Pax2 correlates with increased transactivation of a Pax2-dependent reporter gene, suggesting that serine/threonine phosphorylation of the transactivation domain is important for Pax2 activity. Pax2 can form a complex with the JNK scaffolding protein JIP1, and this interaction is enhanced by activation of the JNK signaling module with the upstream kinase DLK. The data demonstrate that Pax2 is a new target for the JNK signaling module and point to a novel mechanism for mediating Pax-dependent transcription regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700324     DOI: 10.1074/jbc.M109663200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Epigenetic mechanisms of Groucho/Grg/TLE mediated transcriptional repression.

Authors:  Sanjeevkumar R Patel; Samina S Bhumbra; Raghavendra S Paknikar; Gregory R Dressler
Journal:  Mol Cell       Date:  2011-12-08       Impact factor: 17.970

2.  Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance.

Authors:  Qi Cai; Natalia I Dmitrieva; Joan D Ferraris; Heddwen L Brooks; Bas W M van Balkom; Maurice Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 3.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

4.  Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.

Authors:  Ji-Yao Li; Biao-Xin Chai; Weizhen Zhang; Yi-Qing Liu; John B Ammori; Michael W Mulholland
Journal:  Cell Signal       Date:  2007-01-10       Impact factor: 4.315

Review 5.  Advances in early kidney specification, development and patterning.

Authors:  Gregory R Dressler
Journal:  Development       Date:  2009-12       Impact factor: 6.868

6.  Role of PTIP in class switch recombination and long-range chromatin interactions at the immunoglobulin heavy chain locus.

Authors:  Kristopher R Schwab; Sanjeevkumar R Patel; Gregory R Dressler
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

Review 7.  Patterning and early cell lineage decisions in the developing kidney: the role of Pax genes.

Authors:  Gregory R Dressler
Journal:  Pediatr Nephrol       Date:  2011-01-11       Impact factor: 3.714

8.  The Groucho-associated phosphatase PPM1B displaces Pax transactivation domain interacting protein (PTIP) to switch the transcription factor Pax2 from a transcriptional activator to a repressor.

Authors:  Saji Abraham; Raghavendra Paknikar; Samina Bhumbra; Danny Luan; Rohan Garg; Gregory R Dressler; Sanjeevkumar R Patel
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

9.  Papillorenal syndrome-causing missense mutations in PAX2/Pax2 result in hypomorphic alleles in mouse and human.

Authors:  Ramakrishna P Alur; Camasamudram Vijayasarathy; Jacob D Brown; Mohit Mehtani; Ighovie F Onojafe; Yuri V Sergeev; Elangovan Boobalan; Marypat Jones; Ke Tang; Haiquan Liu; Chun-Hong Xia; Xiaohua Gong; Brian P Brooks
Journal:  PLoS Genet       Date:  2010-03-05       Impact factor: 5.917

10.  Comparative analysis of the mammalian WNT4 promoter.

Authors:  Hongshi Yu; Andrew J Pask; Geoffrey Shaw; Marilyn B Renfree
Journal:  BMC Genomics       Date:  2009-09-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.